SPAS
Spectrum Planning & Advisory Services’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $220K | Buy |
+3,522
| New | +$220K | 0.31% | 45 |
|
|
2023
Q3 | – | Sell |
-3,684
| Closed | -$207K | – | 45 |
|
|
2023
Q2 | $207K | Buy |
+3,684
| New | +$207K | 0.31% | 39 |
|
|
2022
Q4 | – | Sell |
-3,816
| Closed | -$249K | – | 42 |
|
|
2022
Q3 | $249K | Sell |
3,816
-95
| -2% | -$6.2K | 0.25% | 45 |
|
|
2022
Q2 | $238K | Sell |
3,911
-1,034
| -21% | -$62.9K | 0.25% | 36 |
|
|
2022
Q1 | $310K | Hold |
4,945
| – | – | 0.28% | 34 |
|
|
2021
Q4 | $375K | Buy |
4,945
+450
| +10% | +$34.1K | 0.34% | 36 |
|
|
2021
Q3 | $503K | Sell |
4,495
-77
| -2% | -$8.62K | 0.49% | 34 |
|
|
2021
Q2 | $740K | Sell |
4,572
-103
| -2% | -$16.7K | 0.71% | 29 |
|
|
2021
Q1 | $570K | Buy |
4,675
+100
| +2% | +$12.2K | 0.59% | 30 |
|
|
2020
Q4 | $700K | Buy |
+4,575
| New | +$700K | 0.75% | 28 |
|